Literature DB >> 3080030

Change in the synthesis of glycosaminoglycans by fibrotic vitreous induced by erythrocytes.

C Katakami, L A Raymond, M J Lipman, A Appel, W W Kao.   

Abstract

Vitreous fibrosis was induced in rabbit eyes by intravitreal injection of erythrocytes. The fibrotic vitreous removed from experimental animals were then incubated with [3H]glucosamine at 37 degrees C for 24 h. The newly synthesized 3H-labeled glycosaminoglycans were isolated by 4 M guanidium hydrochloride extraction followed by pronase digestion. The 3H-labeled glycosaminoglycans were then characterized by gel filtration column chromatography and by specific enzymatic degradation, i.e., hyaluronidase, chondroitinase AC, and/or chondroitinase ABC. The disaccharides derived from chondroitinase ABC degradation were identified by thin-layer chromatography. We previously demonstrated that 91% of the total glycosaminoglycan synthesized by normal vitreous was hyaluronic acid. Our present results indicate that in the fibrotic vitreous, the synthesis of hyaluronic acid was decreased to 26%, whereas the synthesis of chondroitin sulfate increased to 59% of the total newly synthesized glycosaminoglycans. These results suggest that cells present in fibrotic vitreous resemble fibroblasts with respect to their activities in glycosaminoglycans synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080030     DOI: 10.1016/0304-4165(86)90117-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Platelets, but not erythrocytes, significantly affect cytokine release and scaffold contraction in a provisional scaffold model.

Authors:  May Jacobson; Duretti Fufa; Eduardo L Abreu; Sherwin Kevy; Martha M Murray
Journal:  Wound Repair Regen       Date:  2008 May-Jun       Impact factor: 3.617

2.  Red blood cells stimulate human lung fibroblasts to secrete interleukin-8.

Authors:  K Fredriksson; J Lundahl; L Palmberg; D J Romberger; X D Liu; S I Rennard; C M Skold
Journal:  Inflammation       Date:  2003-04       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.